Business ❯ Pharmaceutical Industry

Drug Companies

Pricing Strategies Eli Lilly Market Impact Regulations Public Procurement Corporate Ethics Market Dynamics Suizo Argentina Novo Nordisk Market Competition Sanofi Lawsuits Research and Development Revolution Medicines Price Reductions Investment User Fees Investor Relations Sun Pharmaceutical Industries Legal Settlements Corruption in Business Profitability Eli Lilly and Novo Nordisk Price Agreements BeOne Medicines Leadership Otsuka Pharmaceutical COVID-19 Treatments Bristol Myers Squibb Market Access Price Controls Market Trends GSK Market Strategies Distribution Practices Agios Pharmaceuticals Stealth BioTherapeutics Distribution Companies Market Applications AstraZeneca Droguería Suizo Argentina CEOs Market Research Eli Lilly & Company

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

Targeting mutant KRAS through cyclophilin A, the pill has been made available under an FDA expanded access pathway pending formal review.

One Infusion Cuts LDL by Up to 62% in Early Gene‑Editing Trial

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

FDA Grants Priority Review to Otsuka’s ADHD Drug Centanafadine With July 24 Decision Date

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

FDA Accepts Sonrotoclax NDA, Grants Priority Review for Relapsed Mantle Cell Lymphoma

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

US-EU Trade Deal Imposes 15% Tariff on European Drugs

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research